Allogene Therapeutics (ALLO) Shares Outstanding (Entity) (2018 - 2026)

Allogene Therapeutics (ALLO) Shares Outstanding (Entity) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Allogene Therapeutics 707.96 Mn 707.96 Mn - 345.35 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 345.35 Mn
Mar 31, 2026 244.82 Mn
Dec 31, 2025 229.41 Mn
Sep 30, 2025 223.16 Mn
Jun 30, 2025 220.13 Mn
Mar 31, 2025 218.60 Mn
Dec 31, 2024 212.21 Mn
Sep 30, 2024 209.50 Mn
Jun 30, 2024 209.05 Mn
Mar 31, 2024 170.45 Mn
Dec 31, 2023 168.64 Mn
Sep 30, 2023 168.18 Mn
Jun 30, 2023 167.13 Mn
Mar 31, 2023 145.74 Mn
Dec 31, 2022 144.44 Mn
Sep 30, 2022 144.03 Mn
Jun 30, 2022 143.72 Mn
Mar 31, 2022 143.57 Mn
Dec 31, 2021 142.62 Mn
Sep 30, 2021 142.44 Mn